Skip to content
value.today

AbbVie Inc. vs Athenex

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AbbVie Inc. is the larger company by market value: $514.0 B against $24 M for Athenex, 21417 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Dec 25, 2022 for Athenex). Athenex's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
  • AbbVie Inc. had more revenue: $61.2 B in the year to December 2025 against $144 M for Athenex.
  • AbbVie Inc. made a net profit of $4.2 B, while Athenex made a net loss of $146 M.
  • AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -101.4% for Athenex.
  • AbbVie Inc. employs more people: 57,000 against 605 at Athenex. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $238,017 at Athenex.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0981952933902020202120222023202420252026AbbVie Inc. 390Athenex 2

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$15B$31B$46B$61B201720182019202020212022202320242025AbbVie Inc. $61B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
Athenex
ATNX
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded2013—
Size
Market cap$514.0 B$24 M*
Revenue$61.2 B$144 M
Net income$4.2 B▲ best$-146 M
Employees57,000605
Valuation
P/E ratio49.7×—
Price to sales7.8×—
Free cash flow yield3.5%—
Profitability
Gross margin70.2%—
Operating margin24.6%—
Net margin6.9%—
Return on invested capital16.0%—
Growth
Revenue growth8.6%—
Revenue growth, 3 years a year1.8%—
Earnings per share growth-1.3%—
Financial strength
Interest cover5.2×—
Cash
Free cash flow margin29.1%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Dec 2022

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or Athenex?

AbbVie Inc. is the larger company by market value: $514.0 B against $24 M for Athenex, 21417 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Dec 25, 2022 for Athenex). Athenex's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, AbbVie Inc. or Athenex?

AbbVie Inc. had more revenue: $61.2 B in the year to December 2025 against $144 M for Athenex. AbbVie Inc. made a net profit of $4.2 B, while Athenex made a net loss of $146 M.

Which is more profitable, AbbVie Inc. or Athenex?

AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -101.4% for Athenex.

Which has more employees, AbbVie Inc. or Athenex?

AbbVie Inc. employs more people: 57,000 against 605 at Athenex. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $238,017 at Athenex.

Sources#

Every figure on this page comes from these, with the date shown next to it.